Replies to post #197333 on Xechem International Inc. (fka XKEM)

[AMA1]

Pfizer or Bristol-Myers should buy Xechem out. $0.25 per share (about $875 million) is a steal for a product with over a $1 billion market. They may also find other uses for Nicosan. Instead, they are both trying to develop their own drug for SCD and they are failing at it.

Monty, have you tried talking to these guys? This is our best case scenario. I think.